Entries by Sarah Abelsohn

Did Canada Just Quietly Legalize Psychedelic Therapy? Kind of, but it’s Complicated

Did Canada just legalize Psychedelic therapy? Psychedelic therapies, such as psilocybin therapy for depression and MDMA therapy for PTSD, could soon be legal in Canada, at least for some patients. Over the holidays, Health Canada, a regulatory body similar to the FDA made a change to something called their Special Access Program (SAP). This program, […]

MindMed Delays Project Lucy & Compass Pathways Has a Challenged Patent

MindMed's Project Lucy is Delayed and Compass Pathways Has a Patent Being Challenged. In today's episode, we discuss two companies: MindMed (NASDAQ: MNMD, NEO: MMED); and Compass Pathways (NASDAQ: CMPS). For MindMed, unfortunately, their flagship program, Project Lucy, has been delayed. Project Lucy is attempting to treat Generalized Anxiety Disorder using LSD therapy. MindMed had […]

Spider-Man’s Secret War: How the Web Crawler and Stan Lee Promoted the War on Drugs

Spider-Man's Secret War: How the Web Crawler and Stan Lee Fought the War on Drugs Follow us on Twitter: @PsycSpotlight @Psy_Invest @psy_holy Follow us on Instagram: @psycspotlight @thepsychedelicinvestor To learn more about the emerging psychedelic industry, visit: Psychedelic Spotlight Welcome back to another episode. As Spider-Man: No Way Home swings into theaters, every teenager and […]

,

Interview with Bright Minds Biosciences’ CEO Ian McDonald

In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading on the Canadian Securities Exchange under the symbol $DRUG and on the American OTC market under the symbol $BMBIF. In […]

Why the Psychedelic Drug Market is Experiencing Major Growth

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company's digital media platform ‘Psychedelic Spotlight', factors contributing to a more open-minded approach to psychedelics among the scientific and medical communities, and why investors are seeing the psychedelic market as an opportunity for growth. #business #psychedelics #investments source

Psychedelic Spotlight Interview with Douglas K. Gordon

In this episode of the Psychedelic Spotlight podcast, we connect with Douglas K. Gordon, CEO of Silo Wellness, a wellness company in the psychedelics and functional mushroom marketplace. In our conversation with Douglas, we discuss the company's collaboration with the Bob Marley Estate, and their recent expansion to the Frankfurt Exchange. *To learn more about […]

Psychedelic Spotlight Interview with Joshua White

In this episode of the Psychedelic Spotlight podcast, we speak with Joshua White, the Co-Founder and Director of Fireside Project, the first Psychedelic Peer Support Line. Joshua speaks about the creation of the Fireside Project and the future of the organization. *To learn more about the company featured in this episode and the work they’re […]